Aristotle Capital Management LLC Has $1.07 Billion Stock Holdings in Xylem Inc. (NYSE:XYL)

by · The Cerbat Gem

Aristotle Capital Management LLC lowered its position in Xylem Inc. (NYSE:XYLFree Report) by 3.1% during the second quarter, HoldingsChannel.com reports. The firm owned 9,510,630 shares of the industrial products company’s stock after selling 300,526 shares during the quarter. Xylem makes up approximately 2.2% of Aristotle Capital Management LLC’s holdings, making the stock its 13th largest holding. Aristotle Capital Management LLC’s holdings in Xylem were worth $1,071,087,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of XYL. Spire Wealth Management lifted its holdings in Xylem by 42.7% during the first quarter. Spire Wealth Management now owns 331 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 99 shares in the last quarter. Evergreen Capital Management LLC raised its holdings in Xylem by 1.9% during the fourth quarter. Evergreen Capital Management LLC now owns 5,319 shares of the industrial products company’s stock worth $588,000 after acquiring an additional 100 shares in the last quarter. U.S. Capital Wealth Advisors LLC boosted its position in Xylem by 1.3% during the first quarter. U.S. Capital Wealth Advisors LLC now owns 7,600 shares of the industrial products company’s stock valued at $796,000 after purchasing an additional 100 shares during the last quarter. Great Lakes Advisors LLC grew its stake in Xylem by 1.1% in the first quarter. Great Lakes Advisors LLC now owns 9,148 shares of the industrial products company’s stock valued at $958,000 after purchasing an additional 101 shares in the last quarter. Finally, Harbour Investments Inc. boosted its holdings in shares of Xylem by 1.1% in the 1st quarter. Harbour Investments Inc. now owns 9,017 shares of the industrial products company’s stock valued at $944,000 after buying an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 84.53% of the company’s stock.

Insider Transactions at Xylem

In other Xylem news, CEO Patrick Decker sold 99,648 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $100.84, for a total value of $10,048,504.32. Following the transaction, the chief executive officer now directly owns 287,564 shares of the company’s stock, valued at $28,997,953.76. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Xylem from a “hold” rating to a “buy” rating and boosted their target price for the stock from $104.00 to $120.00 in a report on Tuesday, November 21st. TheStreet upgraded Xylem from a “c+” rating to a “b-” rating in a report on Thursday, August 17th. Oppenheimer raised Xylem from a “market perform” rating to an “outperform” rating and set a $118.00 price target for the company in a report on Thursday, October 19th. Citigroup increased their price target on shares of Xylem from $101.00 to $104.00 and gave the company a “neutral” rating in a report on Wednesday, November 1st. Finally, StockNews.com started coverage on shares of Xylem in a research report on Thursday, October 5th. They issued a “hold” rating for the company. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $118.30.

Read Our Latest Stock Analysis on XYL

Xylem Trading Up 0.9 %

Shares of XYL stock traded up $0.95 during mid-day trading on Wednesday, reaching $106.74. 136,785 shares of the stock traded hands, compared to its average volume of 1,716,965. The stock’s fifty day simple moving average is $95.69 and its two-hundred day simple moving average is $101.78. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $118.58. The company has a quick ratio of 1.21, a current ratio of 1.72 and a debt-to-equity ratio of 0.23. The company has a market cap of $25.73 billion, a price-to-earnings ratio of 43.36, a price-to-earnings-growth ratio of 2.00 and a beta of 1.07.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, October 31st. The industrial products company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.10. Xylem had a net margin of 7.29% and a return on equity of 10.99%. The company had revenue of $2.10 billion for the quarter, compared to analyst estimates of $1.99 billion. During the same quarter in the previous year, the business earned $0.79 earnings per share. Xylem’s revenue was up 52.2% compared to the same quarter last year. On average, research analysts anticipate that Xylem Inc. will post 3.75 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 19th. Shareholders of record on Tuesday, November 21st will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, November 20th. This represents a $1.32 dividend on an annualized basis and a yield of 1.24%. Xylem’s dividend payout ratio (DPR) is currently 54.10%.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).